INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

82,053 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
AA
Alonso Lisa AEVP and Chief HR Officer
DOCHEALTHPEAK PROPERTIES, INC.
Tax withholding
F$4,463
252 sh
Jan 28, 2026Jan 30, 2026
Page 1638 of 2052
← PrevNext →
traded Jan 28, 2026
+2d
SEC Form 4

Evidence

9
MM
McCabe Matthew M.EVP & CMO
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
499 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
PB
Patadia Ankit B.EVP and Treasurer
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
15.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
BR
Bohn Scott RCDO and Head of Lab
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
2,396 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
WA
Wolpert Geoffrey AlanDirector
SMBKSMARTFINANCIAL INC.
Grant or award
A—
808 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
HC
Holmes Rob CChairman, President and CEO
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
9,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
HS
Hammock SamanthaEVP & Chief HR Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$989
87 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
PA
Porter Tracy AEVP and General Counsel
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
36.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$299K
2,500 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
PB
Patadia Ankit B.EVP and Treasurer
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
1,079 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
CS
Cullen SusanSEVP/CFO
FFICFLUSHING FINANCIAL CORP
Tax withholding
F$7,459
480 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Johnson Samuel JPresident
ASOAcademy Sports & Outdoors, Inc.
Tax withholding
F$48K
863 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
171.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
291.5K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Grant or award
A—
71.6K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
70.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
FC
Ford Earl Carlton IVEVP & CFO
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
499 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
291.5K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
SM
Schmit MichaelCFO and Corporate Secretary
RESRPC INC
Tax withholding
F$45K
7,030 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Derivative conversion
C—
128.9K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
MO
Moses Kelvin OChief Financial Officer
DOCHEALTHPEAK PROPERTIES, INC.
Grant or award
A—
33.5K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
110.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
FC
Ford Earl Carlton IVEVP & CFO
ASOAcademy Sports & Outdoors, Inc.
Option exercise
M—
499 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
97 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Derivative conversion
C—
64.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
OA
Ogle David AustinDirector
SMBKSMARTFINANCIAL INC.
Grant or award
A—
808 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$299K
2,501 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,207 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

9
VS
Valentine Andre SChief Financial Officer
CNXCConcentrix Corp
Grant or award
A—
436 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$141K
1,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$65K
543 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$65K
543 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$141K
1,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
11.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
1,925 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

5
BM
Brosius MarkSVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Grant or award
A—
2,702 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
7,680 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence